“I am always humbled to hear about the amazing research work happening in Manchester,” said Sharon. “Having a look at the National Biomarker Centre before the official opening is so exciting.”
Now 60, she will celebrate a quarter of a century free of cancer next year.
Showcasing biomarker research in Manchester
Another person who knows all too well the impact of cancer is Professor Caroline Dive, Director of the National Biomarker Centre. Her grandfather died from brain cancer before she was born. Her mother has undergone surgery on an endometrial tumour, and her father was treated for colon cancer. He passed away aged 95, following a further diagnosis of cancer.
“The impact biomarkers will have on patients’ care can’t be underestimated,” said Professor Dive.
“Doctors will be able to get more information, faster, to determine the best treatment plan for each individual. And it will stop some patients from undergoing unnecessary interventions or treatments that could cause pain or discomfort without providing benefit.
“We are learning how to manage cancer. And that will mean we can give patients longer with their loved ones and a good quality of life.”
